EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Jubilant Pharmova's enterprise value is ₹137,542 Mil.
Jubilant Pharmova's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹65,593 Mil. Therefore, Jubilant Pharmova's EV-to-Revenue for today is 2.10.
The historical rank and industry rank for Jubilant Pharmova's EV-to-Revenue or its related term are showing as below:
BOM:530019'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.17 Med: 1.28 Max: 2.7
Current: 2.1
During the past 13 years, the highest EV-to-Revenue of Jubilant Pharmova was 2.70. The lowest was 0.17. And the median was 1.28.
BOM:530019's EV-to-Revenue is ranked better than 53.91% of 1024
companies
in the Drug Manufacturers industry
Industry Median: 2.285
vs BOM:530019: 2.10
The historical data trend for Jubilant Pharmova's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Jubilant Pharmova's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jubilant Pharmova's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Jubilant Pharmova's EV-to-Revenue falls into.
Jubilant Pharmova's current Enterprise Value is ₹137,542 Mil.
Jubilant Pharmova's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹65,593 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jubilant Pharmova's share price for today is ₹706.25.
Jubilant Pharmova's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹411.85.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jubilant Pharmova EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Jubilant Pharmova's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Jubilant Pharmova (BOM:530019) Business Description
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:530019 has been successfully added to your 